METTL14 is downregulated in HCC, and m6A methylation of USP48 by METTL14 plays a protective role in HCC as USP48 stabilizes SIRT6, which impedes metabolic reprogramming and glycolysis (Du et al., 2021). The gene discussed is SIRT6; the disease is hepatocellular carcinoma.